261 related articles for article (PubMed ID: 19666610)
1. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.
Massaad CA; Washington TM; Pautler RG; Klann E
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13576-81. PubMed ID: 19666610
[TBL] [Abstract][Full Text] [Related]
2. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Murakami K; Murata N; Noda Y; Tahara S; Kaneko T; Kinoshita N; Hatsuta H; Murayama S; Barnham KJ; Irie K; Shirasawa T; Shimizu T
J Biol Chem; 2011 Dec; 286(52):44557-68. PubMed ID: 22072713
[TBL] [Abstract][Full Text] [Related]
3. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.
Stackman RW; Eckenstein F; Frei B; Kulhanek D; Nowlin J; Quinn JF
Exp Neurol; 2003 Nov; 184(1):510-20. PubMed ID: 14637120
[TBL] [Abstract][Full Text] [Related]
4. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.
Dumont M; Wille E; Stack C; Calingasan NY; Beal MF; Lin MT
FASEB J; 2009 Aug; 23(8):2459-66. PubMed ID: 19346295
[TBL] [Abstract][Full Text] [Related]
5. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
7. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
8. Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide.
Ma T; Hoeffer CA; Wong H; Massaad CA; Zhou P; Iadecola C; Murphy MP; Pautler RG; Klann E
J Neurosci; 2011 Apr; 31(15):5589-95. PubMed ID: 21490199
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
10. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
11. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
12. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
13. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
14. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
15. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
Garad M; Edelmann E; Leßmann V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
[TBL] [Abstract][Full Text] [Related]
16. PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
Hongpaisan J; Sun MK; Alkon DL
J Neurosci; 2011 Jan; 31(2):630-43. PubMed ID: 21228172
[TBL] [Abstract][Full Text] [Related]
17. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
18. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.
Massaad CA; Amin SK; Hu L; Mei Y; Klann E; Pautler RG
PLoS One; 2010 May; 5(5):e10561. PubMed ID: 20479943
[TBL] [Abstract][Full Text] [Related]
20. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
